Sigmoid adenocarcinoma treatment cost in Israel typically involves diagnostics like a PET-CT scan running from $1,300 to $1,800 and primary surgical interventions. A colectomy (large bowel resection) costs between $20,500 and $33,500 depending on the complexity and surgical approach used. Total expenses are influenced by the cancer stage and hospital type, with international patients often seeing 30-80% savings compared to the US. Leading treatment centers are located in Tel Aviv, Jerusalem, and Haifa.
Typical Sigmoid Adenocarcinoma Treatment Costs in Israel
Bookimed Expert Insight: For complex gastrointestinal oncology, Sourasky Medical Center (Ichilov) is ideal due to its 90% success rate. Patients seeking personalized care should consider Assuta Medical Center, the largest private clinic in Israel. Advanced surgical cases benefit from pioneers like Dr. Alon Pikarsky at Hadassah Medical Center. Multidisciplinary teams at these JCI-accredited centers ensure high safety standards for international patients.
| Israel | Turkey | Austria | |
| Colectomy (large bowel resection) | from $20,500 | from $6,912 | from $22,000 |
| Chemotherapy for breast cancer | from $22,500 | from $1,200 | from $15,000 |
| Radiation therapy for colorectal cancer | - | from $7,000 | from $12,000 |
Prof. Ofer Merimsky is a leading oncologist specializing in bone and soft tissue tumors at Sourasky Medical Center. His expertise spans decades, with leadership in global oncology societies.
Director of the gastrointestinal tumors institute at Sourasky Medical Center – Dr. Sharon Peled specializes in systemic treatment of digestive tract cancers.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.